U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07426159) titled 'AI-Guided Sarcopenia Risk Assessment and Detection' on Feb. 09.
Brief Summary: Sarcopenia, the age-related decline in muscle mass and function, is a major contributor to frailty, disability, and mortality in older adults. Current diagnostic tools assess muscle quantity or function separately and lack predictive biomarkers, limiting early detection and personalized management. This study proposes an AI-driven framework that integrates multimodal physiological, metabolic, and functional data with wearable sensor monitoring to improve sarcopenia risk assessment and guide individualized interventions.
In Phase 1, we will analyze a larg...